| Shareholder | |||||
|---|---|---|---|---|---|
Jonathan LimCo-Founder, Chairman & CEO | 9.32% | 32.36M | 1.09% | +0 | |
Frazier Life Sciences Management, LP | 7.11% | 24.68M | 0.89% | +1.95M | |
T. Rowe Price Group, Inc. | 6.65% | 23.07M | 0.94% | +6.86M | |
BlackRock, Inc. | 5.81% | 20.15M | 0.32% | +4.55M | |
VR Management, LLC | 4.67% | 16.22M | 0.60% | -166.60K | |
RTW Investments, LP | 4.65% | 16.16M | 4.60% | +16.01M | |
Novartis AG | 3.55% | 12.31M | 0.79% | +0 | |
Vivo Capital, LLC | 3.50% | 12.15M | 0.24% | +2.88M | |
Vanguard Capital Management, LLC | 3.24% | 11.25M | -- | +11.25M | |
Artal Group S.A. | 3.24% | 11.24M | 0.16% | +2.49M | |
Logos Global Management, L.P. | 3.21% | 11.15M | 1.36% | -1.85M | |
Paradigm Biocapital Advisors LP | 2.99% | 10.39M | 1.99% | -3.77M | |
State Street Global Advisors, Inc. | 2.68% | 9.30M | 0.51% | +3.13M | |
Arch Venture Partners, L.P. | 2.04% | 7.09M | 1.85% | -3.96M | |
Geode Capital Management, LLC | 1.73% | 6.00M | <0.01% | +1.07M | |
Cormorant Asset Management, LP | 1.67% | 5.80M | -- | +5.80M | |
Affinity Asset Advisors, LLC | 1.54% | 5.35M | 0.17% | +1.45M | |
Balyasny Asset Management L.P. | 1.48% | 5.14M | 1.45% | +5.05M | |
Janus Henderson Group Ltd. | 1.07% | 3.71M | -- | +3.71M | |
5AM Venture Management, LLC | 1.00% | 3.49M | 0.90% | -1.92M |
